GB9125695D0 - Medical preparations - Google Patents

Medical preparations

Info

Publication number
GB9125695D0
GB9125695D0 GB919125695A GB9125695A GB9125695D0 GB 9125695 D0 GB9125695 D0 GB 9125695D0 GB 919125695 A GB919125695 A GB 919125695A GB 9125695 A GB9125695 A GB 9125695A GB 9125695 D0 GB9125695 D0 GB 9125695D0
Authority
GB
United Kingdom
Prior art keywords
medical preparations
preparations
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919125695A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MASTAVAC Ltd
Original Assignee
MASTAVAC Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MASTAVAC Ltd filed Critical MASTAVAC Ltd
Priority to GB919125695A priority Critical patent/GB9125695D0/en
Publication of GB9125695D0 publication Critical patent/GB9125695D0/en
Priority to AU29546/92A priority patent/AU2954692A/en
Priority to PCT/GB1992/002243 priority patent/WO1993011220A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB919125695A 1991-12-03 1991-12-03 Medical preparations Pending GB9125695D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB919125695A GB9125695D0 (en) 1991-12-03 1991-12-03 Medical preparations
AU29546/92A AU2954692A (en) 1991-12-03 1992-12-03 Medical preparations
PCT/GB1992/002243 WO1993011220A1 (en) 1991-12-03 1992-12-03 Medical preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125695A GB9125695D0 (en) 1991-12-03 1991-12-03 Medical preparations

Publications (1)

Publication Number Publication Date
GB9125695D0 true GB9125695D0 (en) 1992-01-29

Family

ID=10705619

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919125695A Pending GB9125695D0 (en) 1991-12-03 1991-12-03 Medical preparations

Country Status (3)

Country Link
AU (1) AU2954692A (en)
GB (1) GB9125695D0 (en)
WO (1) WO1993011220A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
WO1996008979A1 (en) 1994-09-22 1996-03-28 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
WO1999027071A1 (en) * 1997-11-26 1999-06-03 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
ATE366797T1 (en) * 1999-05-04 2007-08-15 Anhydro Ltd METHOD FOR PRESERVING VIRUSES AND MYCOPLASMA
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
US7045149B2 (en) 1999-09-08 2006-05-16 Cornell Research Foundation, Inc. Ruminal fluid inoculation of calves
WO2002067692A1 (en) * 2001-02-21 2002-09-06 Cornell Research Foundation, Inc. Ruminal fluid inoculation of calves
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
WO2005026203A2 (en) 2003-09-18 2005-03-24 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dna promoters and anthrax vaccines
US8011132B2 (en) * 2004-12-23 2011-09-06 Becker Underwood Inc. Enhanced shelf life and on seed stabilization of liquid bacterium inoculants
DE102006033098A1 (en) * 2006-07-14 2008-01-24 Rebholz, Erich, Dr. Method and device for temporary storage of microbes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1443392A (en) * 1974-02-20 1976-07-21 Grace W R & Co Ruminant feed additive
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DD299213A7 (en) * 1988-05-04 1992-04-09 Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De METHOD FOR STABILIZING A LIVE VIRUS VACCINE AGAINST TEMPERATURE EFFECT
US5695541A (en) * 1990-11-13 1997-12-09 Liphatech, Inc. Process for preparation of bacterial agricultural products

Also Published As

Publication number Publication date
WO1993011220A1 (en) 1993-06-10
AU2954692A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
GB2273987B (en) Tomography
IL99291A0 (en) Cosmetic preparations
GB9222888D0 (en) Tomography
GB9121204D0 (en) Medicament
HU911672D0 (en) Tfg-beta preparations
GB9125695D0 (en) Medical preparations
GB9121463D0 (en) Medicament
HU9201364D0 (en) Medical preparations contqining bafilomycin microlides
GB2255721B (en) Medical devices
HU905823D0 (en) Medical preparations
HU9200644D0 (en) Medical preparatives
GB9125761D0 (en) Medical preparations
GB9113970D0 (en) Therapeutic preparations
HU913714D0 (en) Medical preparation
ZA924111B (en) Pharmaceutical preparations
GB9108666D0 (en) New medical uses
GB9102377D0 (en) Medicine
HU905867D0 (en) Medical preparation
HUT64457A (en) Medical cigarette-holder
GB9220581D0 (en) Medicament
GB9210594D0 (en) Medical use
GB9210576D0 (en) Medical use
GB9210595D0 (en) Medical use
GB9014367D0 (en) Pharmaceutical preparations
GB9014354D0 (en) Pharmaceutical preparations